Results 41 to 50 of about 20,838 (225)
Metallothionein immunoexpression in oral leukoplakia [PDF]
, 2008 Objectives: to report the immunoexpression of metallothionein in oral leukoplakia and to correlate with histological grade and clinical localization. Leukoplakia is the most common potentially malignant lesion of the oral cavity.
Aguiar, Maria Cássia Ferreira +5 more
core
Proliferative verrucous leukoplakia, squamous cell carcinoma and axillary metastasis [PDF]
, 2010 Proliferative verrucous leukoplakia (PVL) is an aggressive form of oral leukoplakia with multifocal presentation, high rates of recurrence and malignant transformation.
Almeida, Oslei Paes de +4 more
core +1 more source
β‐Adrenergic Signaling Promotes Anti‐Tumor Immunity in TP53‐mutant Oral Squamous Cell Carcinoma
Advanced Science, EarlyView.β‐adrenergic stimulation enhances anti‐tumor immunity in TP53‐deficient oral squamous cell carcinoma by inducing tumor‐derived secretion of CXCL10, which attracts and activates cytotoxic CD8+ T cells. The findings demonstrate that β‐adrenergic signaling alters tumor–immune interactions via CXCL10‐mediated paracrine activation, revealing a neuro‐immune ...
Frederico O. Gleber‐Netto +20 more
wiley +1 more source
BMC Oral HealthBackground Clinicopathological diagnosis and follow-up of oral lichen planus and leukoplakia are necessary due to its potential for malignant transformation and the need to differentiate it from other lichenoid diseases and proliferative verrucous ...
Milena Duarte Moreira +7 more
doaj +1 more source
Journal of Dr. NTR University of Health Sciences, 2018 Objective: To evaluate the quantitative expression of Ki-67 in oral leukoplakia, oral submucous fibrosis (OSF) and to compare their expression with normal oral epithelium.
Mani D Chitipothu +5 more
doaj +1 more source
Oral cancer in the UK: to screen or not to screen. [PDF]
, 1998 Although oral squamous cell carcinoma accounts for only a small proportion of malignant neoplasms in the UK, oral cancer incidence and mortality rates have been rising in recent years.
Rodrigues, Veena
core
CO2 lasers in the management of potentially malignant and malignant oral disorders [PDF]
, 2012 The CO2 laser was invented in 1963 by Kumar Patel. Since the early 1970s, CO2 laser has proved to be an effective method of treatment for patients with several types of oral lesions, including early squamous cell carcinoma.
Hamdoon, Z, Hopper, C, Jerjes, W
core +1 more source
Head &Neck, EarlyView.ABSTRACT Background The gingiva and floor of the mouth are distinct subsites, and oral squamous cell carcinoma (OSCC) originating in these locations warrants further indepth understanding. Methods This study enrolled patients with OSCC from 2000 to 2020, and analyzed the clinicopathological characteristics.
Hao Li +12 more
wiley +1 more source
Journal of Dental Education, EarlyView.ABSTRACT Objectives This study provides a descriptive, multi‐institutional comparison of dental students' recognition accuracy and management decisions of oral soft tissue pathological entities across four US dental schools. While prior single‐institution studies have evaluated diagnostic ability, this work provides a multi‐institutional comparison to ...
Nicole McKee +7 more
wiley +1 more source
Scientific Reports, 2023 The programmed cell death protein (PD-1)/programmed cell death protein ligand (PD-L1) pathway and cytotoxic T lymphocyte antigen are the most important co-stimulatory molecules that play a key role in the negative regulation of T cells during ...
L. R. Greeshma +4 more
doaj +1 more source